Our finding of no increase in cardiomyocyte width of diabetic and MetS patients is in agreement with reports of similar cardiac mass for diabetic and non-diabetic individuals [35], and the association between increased insulin levels and cardiac hypertrophy is largely accounted for by associations with body size [36]. The gene discussed is INS; the disease is metabolic syndrome.